Reaction Details |
| Report a problem with these data |
Target | Neuropeptide Y receptor type 2 |
---|
Ligand | BDBM42438 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism |
---|
IC50 | 29590±n/a nM |
---|
Citation | PubChem, PC Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism PubChem Bioassay(2008)[AID] |
---|
More Info.: | Get all data from this article, Solution Info, Assay Method |
---|
|
Neuropeptide Y receptor type 2 |
---|
Name: | Neuropeptide Y receptor type 2 |
Synonyms: | NPY-Y2 | NPY-Y2 receptor | NPY2-R | NPY2R | NPY2R_HUMAN | Neuropeptide Y receptor type 2 | Y2 receptor | neuropeptide Y receptor Y2 |
Type: | Enzyme Catalytic Domain |
Mol. Mass.: | 42734.65 |
Organism: | Homo sapiens (Human) |
Description: | NPY-Y2 NPY2R HUMAN::P49146 |
Residue: | 381 |
Sequence: | MGPIGAEADENQTVEEMKVEQYGPQTTPRGELVPDPEPELIDSTKLIEVQVVLILAYCSI
ILLGVIGNSLVIHVVIKFKSMRTVTNFFIANLAVADLLVNTLCLPFTLTYTLMGEWKMGP
VLCHLVPYAQGLAVQVSTITLTVIALDRHRCIVYHLESKISKRISFLIIGLAWGISALLA
SPLAIFREYSLIEIIPDFEIVACTEKWPGEEKSIYGTVYSLSSLLILYVLPLGIISFSYT
RIWSKLKNHVSPGAANDHYHQRRQKTTKMLVCVVVVFAVSWLPLHAFQLAVDIDSQVLDL
KEYKLIFTVFHIIAMCSTFANPLLYGWMNSNYRKAFLSAFRCEQRLDAIHSEVSVTFKAK
KNLEVRKNSGPNDSFTEATNV
|
|
|
BDBM42438 |
---|
n/a |
---|
Name | BDBM42438 |
Synonyms: | (2Z)-3-ethyl-2-[[3-methyl-5-(2-methylphenyl)-1,3-thiazol-3-ium-2-yl]methylidene]-1,3-benzothiazole;iodide | (2Z)-3-ethyl-2-[[3-methyl-5-(2-methylphenyl)-2-thiazol-3-iumyl]methylidene]-1,3-benzothiazole;iodide | (2Z)-3-ethyl-2-[[3-methyl-5-(o-tolyl)thiazol-3-ium-2-yl]methylene]-1,3-benzothiazole;iodide | 3-ethyl-2-{(Z)-[3-methyl-5-(2-methylphenyl)-1,3-thiazol-2(3H)-ylidene]methyl}-1,3-benzothiazol-3-ium | MLS000727848 | SMR000306545 | cid_16188793 |
Type | Small organic molecule |
Emp. Form. | C21H21N2S2 |
Mol. Mass. | 365.534 |
SMILES | CCN1\C(Sc2ccccc12)=C\c1sc(c[n+]1C)-c1ccccc1C |
Structure |
|